GlobeNewswire·Oct 15, 2026, 8:45 AM ET

The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape

TEM AIRDF HWAIF IQV WHTCF

The global AI healthcare market was valued at $39.34 billion in 2025, with Fortune Business Insights projecting growth to $56.01 billion in 2026 & $1.03 trillion by 2034.
Grand View Research estimates the market could reach $505.59 billion by 2033, reflecting a 38.9% annual growth rate from 2025 through 2033.
Key growth drivers include early disease detection, faster drug discovery, lower operating costs through automation, personalized medicine, & expanding commercial markets.
Rocket Doctor AI completed 53,348 patient visits in Q3 2026, featuring a 56% quarter-over-quarter increase in U.S. visits & a 24% year-over-year increase in Canadian visits.
Rocket Doctor AI expects record quarterly revenue for Q3 2026 as U.S. patient volumes rise & cash collections align with clinical activity.
WELLSTAR Technologies Corp., a subsidiary of WELL Health Technologies, completed an amalgamation & will begin trading on the TSX Venture Exchange under the ticker "WSTR" on October 1, 2026.
Tempus announced an expanded multi-year collaboration to support the commercialization of intismeran autogene, a novel therapy developed by Moderna & Merck, for melanoma patients.
IQVIA & Veeva Systems expanded their partnership by adopting Veeva CTMS, eTMF, Study Startup, & Site Connect as enterprise standards across IQVIA clinical development studies.
HEALWELL AI published peer-reviewed research showing its VeroSource MyHealth app improved patient empowerment & reduced unnecessary healthcare interactions, with 65% of New Brunswick users reporting increased engagement.